A detailed history of Centerpoint Advisors, LLC transactions in Haleon PLC stock. As of the latest transaction made, Centerpoint Advisors, LLC holds 110 shares of HLN stock, worth $1,054. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110
Holding current value
$1,054
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

BUY
$8.72 - $10.35 $959 - $1,138
110 New
110 $1,000
Q1 2023

May 03, 2023

BUY
$7.57 - $8.37 $4,163 - $4,603
550 Added 112.24%
1,040 $8,000
Q3 2022

Oct 13, 2022

BUY
$5.63 - $7.5 $2,758 - $3,675
490 New
490 $3,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Centerpoint Advisors, LLC Portfolio

Follow Centerpoint Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Centerpoint Advisors, LLC with notifications on news.